Abstract
Concern about the ethics of clinical drug trials research on patients and healthy volunteers has been the subject of significant ethical analysis and policy development—protocols are reviewed by Research Ethics Committees and subjects are protected by informed consent procedures. More recently attention has begun to be focused on DNA banking for clinical and pharmacogenetics research. It is, however, surprising how little attention has been paid to the commercial nature of such research, or the unique issues that present when subjects are asked to consent to the storage of biological samples. Our contention is that in the context of pharmacogenetic add-on studies to clinical drug trials, the doctrine of informed consent fails to cover the broader range of social and ethical issues. Applying a sociological perspective, we foreground issues of patient/subject participation or ‘work’, the ambiguity of research subject altruism, and the divided loyalties facing many physicians conducting clinical research. By demonstrating the complexity of patient and physician involvement in clinical drug trials, we argue for more comprehensive ethical review and oversight that moves beyond reliance on informed consent to incorporate understandings of the social, political and cultural elements that underpin the diversity of ethical issues arising in the research context
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1016/j.shpsc.2006.06.004
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 71,355
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

Inducement in Research.Martin Wilkinson & Andrew Moore - 1997 - Bioethics 11 (5):373-389.
The Ethical Analysis of Risk.Charles Weijer - 2000 - Journal of Law, Medicine and Ethics 28 (4):344-361.

View all 14 references / Add more references

Citations of this work BETA

Add more citations

Similar books and articles

Mitigation Banking and The Problem of Consolidation.Gordon Steinhoff - 2008 - Proceedings of the Xxii World Congress of Philosophy 23:147-154.
Genotyping in Clinical Trials: Towards a Principle of Informed Request.Hans-Martin Sass - 1998 - Journal of Medicine and Philosophy 23 (3):288 – 296.
Are Banking Crises Free‐Market Phenomena?George Selgin - 1994 - Critical Review: A Journal of Politics and Society 8 (4):591-608.
The Free Banking Challenge to Central Banks.Charles A. E. Goodhart - 1994 - Critical Review: A Journal of Politics and Society 8 (3):411-425.
A Consumer Perspective on Forensic DNA Banking.Sharon F. Terry & Patrick F. Terry - 2006 - Journal of Law, Medicine and Ethics 34 (2):408-414.
Ethical Investment.Joakim Sandberg - 2013 - In Hugh LaFollette (ed.), The International Encyclopedia of Ethics. Wiley-Blackwell.

Analytics

Added to PP index
2010-08-30

Total views
51 ( #224,201 of 2,519,576 )

Recent downloads (6 months)
1 ( #407,153 of 2,519,576 )

How can I increase my downloads?

Downloads

My notes